Trials / Active Not Recruiting
Active Not RecruitingNCT07458022
MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Role of Magnesium in Depressive Disorder
Detailed description
Because of the significant role that magnesium serves in mood regulation, the goal of this study is to evaluate the impact of starting the therapy of major depressive disorder with a combination of SSRI and Mg, as well as SSRI alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Use of magnesium with SSRI | Impact of combination of SSRI and Magnesium in Major Depressive Disorder |
| DRUG | SSRI | Only SSRI will be given |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2026-03-09
- Last updated
- 2026-03-09
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07458022. Inclusion in this directory is not an endorsement.